Linden Advisors’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History
Bought
Maintained
Sold
Other funds holding OACC
Linden Advisors's OACC Position: Q3 2026 in Review
Linden Advisors held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q3 2026 at 600,000 shares worth $6.46M. The position accounts for 0.03% of the portfolio, ranked #296.
Linden Advisors first reported a position in OACC in Q1 2025 and has held it in 7 quarters since. 41 funds tracked by Wall St. Rank hold OACC as of Q3 2026.
- Linden Advisors held 600,000 shares of Oaktree Acquisition Corp III Life Sciences worth $6.46M as of Q3 2026.
- Linden Advisors left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q3 2026.
- Oaktree Acquisition Corp III Life Sciences made up 0.03% of Linden Advisors's portfolio in Q3 2026, its #296 holding.
- Linden Advisors first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 7 quarters since.
- 41 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q3 2026.
Based on Linden Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.